• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人食管癌中int-2和erbB基因扩增:与临床病理变量的关系

Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables.

作者信息

Suzuki H, Abo S, Kitamura M, Hashimoto M, Izumi K, Terada K, Sugiyama T

机构信息

Second Department of Surgery, Akita University School of Medicine, Japan.

出版信息

Cancer Invest. 1997;15(5):411-5. doi: 10.3109/07357909709047579.

DOI:10.3109/07357909709047579
PMID:9316622
Abstract

Gene amplification is a relatively frequent event in human malignant tumors and is believed to play an important role in tumor progression. The int-2 and erbB genes are amplified more frequently than any other genes in human esophageal cancer. In order to investigate the correlation between these two proto-oncogenes and the clinical behavior of esophageal cancer, we examined DNA amplification of int-2 and erbB and analyzed their relationship to clinicopathological variables. Genomic DNA was extracted from 21 esophageal squamous carcinomas and normal esophageal mucosa, as well as from 4 metastatic tumors. We used Southern blot analysis for detection of gene amplification. Amplification of int-2 was observed in 13 of 21 cases (62%) and in all the metastatic tumors (4/4; 100%). We found a significant correlation between amplification of int-2 and the length of the primary lesion. Amplification of erbB was detected in 3 of 18 patients (17%). All patients who showed amplification of erbB also demonstrated amplification of int-2. These results suggest that amplification of int-2 or neighboring genes on 11q may participate in tumor progression and metastasis in patients with esophageal squamous cancer.

摘要

基因扩增在人类恶性肿瘤中是较为常见的事件,并且被认为在肿瘤进展过程中发挥重要作用。在人类食管癌中,int-2和erbB基因的扩增比其他任何基因都更为频繁。为了研究这两个原癌基因与食管癌临床行为之间的相关性,我们检测了int-2和erbB的DNA扩增情况,并分析了它们与临床病理变量之间的关系。从21例食管鳞状细胞癌、正常食管黏膜以及4例转移瘤中提取基因组DNA。我们采用Southern印迹分析法检测基因扩增。在21例病例中有13例(62%)观察到int-2扩增,并且在所有转移瘤中均有int-2扩增(4/4;100%)。我们发现int-2扩增与原发灶长度之间存在显著相关性。在18例患者中有3例(17%)检测到erbB扩增。所有显示erbB扩增的患者也都有int-2扩增。这些结果表明,int-2或11q上的邻近基因的扩增可能参与食管鳞状细胞癌患者的肿瘤进展和转移。

相似文献

1
Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables.人食管癌中int-2和erbB基因扩增:与临床病理变量的关系
Cancer Invest. 1997;15(5):411-5. doi: 10.3109/07357909709047579.
2
Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas.食管浅表鳞状细胞癌中c-erbB和int-2扩增的意义。
Ann Thorac Surg. 1996 Sep;62(3):835-8. doi: 10.1016/s0003-4975(96)00392-x.
3
High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas.人类食管癌中hst-1和int-2基因共扩增的高发生率。
Cancer Res. 1989 Oct 15;49(20):5505-8.
4
Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.应用差异聚合酶链反应检测子宫内膜癌中c-erbB-2/neu和纤维母细胞生长因子-3/INT-2基因,但未检测到表皮生长因子受体基因扩增。
Cancer. 1995 Apr 15;75(8):2139-46. doi: 10.1002/1097-0142(19950415)75:8<2139::aid-cncr2820750817>3.0.co;2-6.
5
Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma.
Cancer Res. 1991 Mar 1;51(5):1504-8.
6
[The significance of c-erbB-2 and int-2 gene alterations and DNA ploidy pattern for aggressiveness of breast cancer].[c-erbB-2和int-2基因改变及DNA倍体模式对乳腺癌侵袭性的意义]
Nihon Geka Gakkai Zasshi. 1993 Oct;94(10):1144-52.
7
Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.在原发性人类乳腺癌中,与c-myc和c-erbB-2/neu扩增相比,Int-2/FGF3扩增是复发更好的独立预测指标。
Mod Pathol. 1994 Dec;7(9):900-5.
8
Prognostic significance of hst-1 gene amplification in primary esophageal carcinomas and its relationship to other prognostic factors.hst-1基因扩增在原发性食管癌中的预后意义及其与其他预后因素的关系。
Anticancer Res. 1994 Mar-Apr;14(2B):651-6.
9
A paradigm for oncogene complementation in human breast cancer.
Res Virol. 1989 Nov-Dec;140(6):571-91. doi: 10.1016/s0923-2516(89)80143-8.
10
Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis.淋巴结阴性乳腺癌中c-erbB-2、int-2和c-myc基因的扩增。与预后的关系。
Acta Oncol. 1993;32(3):289-94. doi: 10.3109/02841869309093597.

引用本文的文献

1
FAM175B promotes apoptosis by inhibiting ATF4 ubiquitination in esophageal squamous cell carcinoma.FAM175B 通过抑制食管鳞癌细胞中 ATF4 的泛素化促进细胞凋亡。
Mol Oncol. 2019 May;13(5):1150-1165. doi: 10.1002/1878-0261.12474. Epub 2019 Mar 23.
2
Expression levels of HER2 and MRP1 are not prognostic factors of long-term survival in 829 patients with esophageal squamous cell carcinoma.HER2和MRP1的表达水平并非829例食管鳞状细胞癌患者长期生存的预后因素。
Oncol Lett. 2016 Jan;11(1):745-752. doi: 10.3892/ol.2015.3975. Epub 2015 Nov 25.
3
A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.
食管癌生存、治疗反应及分期的体细胞和生殖系DNA序列生物标志物的系统评价与荟萃分析。
Ann Oncol. 2015 Apr;26(4):624-644. doi: 10.1093/annonc/mdu449. Epub 2014 Sep 11.
4
Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma.食管鳞状细胞癌中 HER2 基因扩增和蛋白表达的分析。
Med Oncol. 2012 Jun;29(2):933-40. doi: 10.1007/s12032-011-9850-y. Epub 2011 Feb 13.
5
Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma.表皮生长因子受体和细胞周期蛋白D1在食管鳞状细胞癌中独立扩增并过度表达。
J Cancer Res Clin Oncol. 2005 Feb;131(2):111-9. doi: 10.1007/s00432-004-0610-7. Epub 2004 Oct 19.